Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.22.2.2
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of product warranty accrual
           
   

June 30,

2022

   

December 31,

2021

 
Beginning balance   $ 46,650     $ 45,328  
Warranty claims incurred     (2,890 )     (16,075 )
Provision charged (credited) to expense     3,047       17,397  
Ending balance   $ 46,807     $ 46,650  
Schedule of earnings per share
                               
   

Three Months Ended

June 30

   

Six Months Ended

June 30

 
    2022     2021     2022     2021  
Net Income / (Loss)   $ 8,747     $ (155,595 )   $ (509,081 )   $ (72,856 )
Less: cumulative dividends earned on Series A and Series B Preferred Stock     (14,077 )     (26,344 )     (46,498 )     (47,032 )
Net Income / (Loss) Attributable to common shareholders   $ (5,330 )   $ (181,939 )   $ (555,579 )   $ (119,888 )

 

Schedule of weighted average diluted shares
                               
   

Three Months Ended

June 30

   

Six Months Ended

June 30

 
    2022     2021     2022     2021  
Weighted average common shares outstanding - basic   $ 299,212,282     $ 136,311,335     $ 293,782,250     $ 136,311,335  
Dilutive effect of stock options                        
Weighted average common shares outstanding - diluted   $ 299,212,282     $ 136,311,335     $ 293,782,250     $ 136,311,335